235 related articles for article (PubMed ID: 16813739)
1. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
Hlatky MA; Melsop KA; Boothroyd DB;
Am J Cardiol; 2006 Jun; 97(12A):59G-65G. PubMed ID: 16813739
[TBL] [Abstract][Full Text] [Related]
2. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Brooks MM; Frye RL; Genuth S; Detre KM; Nesto R; Sobel BE; Kelsey SF; Orchard TJ;
Am J Cardiol; 2006 Jun; 97(12A):9G-19G. PubMed ID: 16813734
[TBL] [Abstract][Full Text] [Related]
3. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Barsness GW; Gersh BJ; Brooks MM; Frye RL;
Am J Cardiol; 2006 Jun; 97(12A):31G-40G. PubMed ID: 16813736
[TBL] [Abstract][Full Text] [Related]
4. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Magee MF; Isley WL;
Am J Cardiol; 2006 Jun; 97(12A):20G-30G. PubMed ID: 16813735
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
[TBL] [Abstract][Full Text] [Related]
6. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
[TBL] [Abstract][Full Text] [Related]
7. Statement of the problem.
Steiner G;
Am J Cardiol; 2006 Jun; 97(12A):3G-8G. PubMed ID: 16813733
[TBL] [Abstract][Full Text] [Related]
8. Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial: Synergies and opportunities.
Sobel BE;
Am J Cardiol; 2006 Jun; 97(12A):53G-58G. PubMed ID: 16813738
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery bypass grafting (CABG): reassessing efficacy, safety, and cost.
Cundiff DK
MedGenMed; 2002 Jun; 4(2):7. PubMed ID: 12145567
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
11. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
Szucs TD; Schwenkglenks M; Rutishauser W
Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
[TBL] [Abstract][Full Text] [Related]
12. Myocardial revascularization in 1997: angioplasty versus bypass surgery.
Faxon DP
Am Fam Physician; 1997 Oct; 56(5):1409-18. PubMed ID: 9337763
[TBL] [Abstract][Full Text] [Related]
13. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database.
McGuire DK; Anstrom KJ; Peterson ED
Circulation; 2003 Apr; 107(14):1864-70. PubMed ID: 12668513
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
Claude J; Schindler C; Kuster GM; Schwenkglenks M; Szucs T; Buser P; Osswald S; Kaiser C; Grädel C; Estlinbaum W; Rickenbacher P; Pfisterer M;
Eur Heart J; 2004 Dec; 25(24):2195-203. PubMed ID: 15589636
[TBL] [Abstract][Full Text] [Related]
15. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
Favarato D; Hueb W; Gersh BJ; Soares PR; Cesar LA; da Luz PL; Oliveira SA; Ramires JA;
Circulation; 2003 Sep; 108 Suppl 1():II21-3. PubMed ID: 12970202
[TBL] [Abstract][Full Text] [Related]
16. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Hlatky MA; Boothroyd DB; Melsop KA; Kennedy L; Rihal C; Rogers WJ; Venkitachalam L; Brooks MM;
Circulation; 2009 Dec; 120(25):2550-8. PubMed ID: 19920002
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery bypass graft vs. percutaneous coronary angioplasty: CABG on the rebound?
Taggart DP
Curr Opin Cardiol; 2007 Nov; 22(6):517-23. PubMed ID: 17921738
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
Kuller LH
Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
[TBL] [Abstract][Full Text] [Related]
19. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Goldfine AB; Fonseca V
Circulation; 2010 Jun; 121(22):2447-9. PubMed ID: 20530022
[No Abstract] [Full Text] [Related]
20. Integrated management of patients with diabetes mellitus and ischemic heart disease: PCI, CABG, and medical therapy.
Barsness GW; Holmes DR; Gersh BJ
Curr Probl Cardiol; 2005 Nov; 30(11):583-617. PubMed ID: 16230183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
